dapsone has been researched along with Allergic Reaction in 11 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Dapsone hypersensitivity syndrome (DHS) is restricted to HLA-B∗13:01." | 8.31 | TAP2 Drives HLA-B∗13:01‒Linked Dapsone Hypersensitivity Syndrome Tolerance and Reactivity. ( Liu, H; Liu, T; Mi, Z; Sun, L; Sun, Y; Wang, Z; Xue, X; You, J; Yu, G; Yue, Z; Zhang, F; Zhao, Q, 2023) |
| "Dapsone has potent anti-inflammatory effects, and is used in the treatment of leprosy, cutaneous vasculitis, neutrophilic dermatoses, and dermatitis herpetiformis and other blistering disorders." | 7.75 | Dapsone hypersensitivity syndrome with circulating 190-kDa and 230-kDa autoantibodies. ( Chun, JS; Kim, SJ; Lee, JB; Lee, SC; Won, YH; Yun, SJ, 2009) |
| "Dapsone hypersensitivity syndrome (DHS) is restricted to HLA-B∗13:01." | 4.31 | TAP2 Drives HLA-B∗13:01‒Linked Dapsone Hypersensitivity Syndrome Tolerance and Reactivity. ( Liu, H; Liu, T; Mi, Z; Sun, L; Sun, Y; Wang, Z; Xue, X; You, J; Yu, G; Yue, Z; Zhang, F; Zhao, Q, 2023) |
| "Dapsone has potent anti-inflammatory effects, and is used in the treatment of leprosy, cutaneous vasculitis, neutrophilic dermatoses, and dermatitis herpetiformis and other blistering disorders." | 3.75 | Dapsone hypersensitivity syndrome with circulating 190-kDa and 230-kDa autoantibodies. ( Chun, JS; Kim, SJ; Lee, JB; Lee, SC; Won, YH; Yun, SJ, 2009) |
| "Dapsone intermediates were characterized by mass spectrometry." | 1.51 | Dapsone- and nitroso dapsone-specific activation of T cells from hypersensitive patients expressing the risk allele HLA-B*13:01. ( Alhilali, K; Almutairi, M; Alzahrani, A; Amjad, J; Gibson, A; Kevin Park, B; Liu, H; Liu, J; Meng, X; Naisbitt, DJ; Ogese, MO; Ostrov, DA; Sun, L; Sun, Y; Zhang, F; Zhang, H; Zhao, Q, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (27.27) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 3 (27.27) | 2.80 |
| Authors | Studies |
|---|---|
| Muddebihal, A | 1 |
| Sardana, K | 1 |
| Khurana, A | 1 |
| Sachdeva, S | 1 |
| Singh, I | 1 |
| Ahuja, M | 1 |
| Sharma, R | 1 |
| Zhao, Q | 3 |
| Sun, L | 3 |
| Sun, Y | 3 |
| Naisbitt, D | 1 |
| Liu, H | 3 |
| Zhang, F | 3 |
| Wang, Z | 1 |
| Liu, T | 1 |
| Yu, G | 1 |
| Xue, X | 1 |
| You, J | 1 |
| Yue, Z | 1 |
| Mi, Z | 1 |
| Alhilali, K | 1 |
| Alzahrani, A | 1 |
| Almutairi, M | 1 |
| Amjad, J | 1 |
| Zhang, H | 1 |
| Meng, X | 1 |
| Gibson, A | 1 |
| Ogese, MO | 1 |
| Kevin Park, B | 1 |
| Liu, J | 1 |
| Ostrov, DA | 1 |
| Naisbitt, DJ | 1 |
| Chun, JS | 1 |
| Yun, SJ | 1 |
| Kim, SJ | 1 |
| Lee, SC | 1 |
| Won, YH | 1 |
| Lee, JB | 1 |
| Wozel, VE | 1 |
| HAUZEUR, AC | 1 |
| Biswas, SK | 1 |
| Pavithran, K | 1 |
| Bindu, V | 1 |
| Heszler, E | 1 |
| Husz, S | 1 |
| Wells, GC | 1 |
11 other studies available for dapsone and Allergic Reaction
| Article | Year |
|---|---|
A prospective case control study of resistance to rifampicin, dapsone and ofloxacin in Type 1 and Type 2 leprosy reactions and the therapeutic impact of modified treatment regimen on reactions.
Topics: Case-Control Studies; Dapsone; Drug Therapy, Combination; Humans; Hypersensitivity; Leprostatic Agen | 2023 |
Dapsone hypersensitivity syndrome.
Topics: Dapsone; Drug Hypersensitivity; Humans; Hypersensitivity; Syndrome | 2023 |
TAP2 Drives HLA-B∗13:01‒Linked Dapsone Hypersensitivity Syndrome Tolerance and Reactivity.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 3; Dapsone; Drug Hypersensitivity Syndrome; Ep | 2023 |
Dapsone- and nitroso dapsone-specific activation of T cells from hypersensitive patients expressing the risk allele HLA-B*13:01.
Topics: Adult; Cross Reactions; Dapsone; Female; Gene Expression; HLA-B Antigens; Humans; Hypersensitivity; | 2019 |
Dapsone hypersensitivity syndrome with circulating 190-kDa and 230-kDa autoantibodies.
Topics: Adult; Autoantibodies; Dapsone; Dermatologic Agents; Drug Eruptions; Female; Humans; Hypersensitivit | 2009 |
Innovative use of dapsone.
Topics: Adult; Anti-Infective Agents; Autoimmune Diseases; Child; Dapsone; Humans; Hypersensitivity; Jaundic | 2010 |
[Concerning the eradication of leprosy? Influence of ambulatory treatment of leprosy, with DADPS, on the progression of leprous endemia and its results (1953-1959). Additional note on the relation existing between leprosy and allergy to tuberculin and the
Topics: Dapsone; Humans; Hypersensitivity; Immune System Diseases; Leprosy; Mycobacterium bovis; Sulfones; T | 1960 |
Chemotherapy of leprosy.
Topics: Anti-Bacterial Agents; Clofazimine; Dapsone; Dose-Response Relationship, Drug; Drug Combinations; Dr | 2004 |
Dapsone syndrome: hepatitis-B infection a risk factor for its development?
Topics: Adult; Amyloidosis; Dapsone; Female; Hepatitis B; Humans; Hypersensitivity; Leprosy; Lichenoid Erupt | 1999 |
[Superficial allergic vasculitides. Review and own cases].
Topics: Adult; Arteritis; Dapsone; Female; Humans; Hypersensitivity; Male; Purpura; Streptococcus | 1970 |
Allergic vasculitis(tri-symptom of Gougerot) treated with dapsone.
Topics: Adult; Dapsone; Female; Humans; Hypersensitivity; Purpura; Vascular Diseases | 1969 |